Martin Puhr

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 09, 2025
Correction: Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.

Anita Csizmarik, Nikolett Nagy, Dávid Keresztes

|May 12, 2025
Repurposing Amiodarone for Bladder Cancer Treatment.

Francisco J Roa, Maria Roubelakis, Konstantinos Paschidis

|Sep 14, 2024
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism Manipulation.

Pia V Hönscheid, Gustavo B Baretton, Martin Puhr

|May 15, 2024
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer.

Alicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano

|Aug 26, 2023
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.

Anita Csizmarik, Nikolett Nagy, Dávid Keresztes

Pageof 2